Obesity is one of the major medical conditions that is affecting millions of individuals worldwide. New approaches in obesity treatment are being constantly developed. This includes personalized approaches that combines genetics, microbiology, and behavioural science. Additionally, tailored or well optimised interventions are being developed that leverages the discipline of genetics to create optimized personalized medications.
The microbiome's role in metabolism is being explored, with probiotics and prebiotics showing promise in managing weight. This altogether inclusive approaches mark a new direction in the obesity treatment in the quest for ensuring safer and healthier future.
Scientists and healthcare professionals who are engaged in the study of the interactions between metabolic diseases and chronic illnesses to the extent that they have produced a significant body of work in the medical and healthcare fields may want to consider submitting their abstracts to the Metabolic Disorders Conference. This is because they are sure to discover herein a world-class platform where they will be able to put their research and practice findings to good use.